Using the Cox model adjusted according to age at diagnosis for a multivariate analysis, pathological response to primary chemotherapy and both two ERCC1 polymorphisms remained the only parameters with a significant impact on prognosis in our series of breast cancer patients; no other association with overall survival was observed for the remaining variables (Table 3A). The gene discussed is ERCC1; the disease is breast cancer.